| Biomarker ID | 1271 |
| PMID | 24371517 |
| Year | 2013 |
| Biomarker | ITGA3; ITGB1; TLN1; VCL; ITGA1; FLNC; |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Cell Lines |
| Subjects | Humans |
| Regulation | Differentially Expressed |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | cell adhesion, cell-matrix adhesion and integrin-mediated signalling pathway |
| Experiment | LNCaP Cell Lines Vs PC-3 Cell Lines |
| Type of Biomarker | Prognostic |
| Cohort | Exosomes from LNCaP and PC-3 cancer cell lines were chosen for analysis |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | Liquid chromatography–mass spectrometry |
| Clinical | No |
| Remarks | PC3 is hormone-independently growing, more aggressive and LNCaP is hormone depen- dently, less aggressive |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on Human Patient Cohort |
| Technical Name | ITGA3, ITGB1, TLN1, VCL, ITGA1, FLNC |